NxStage Medical, Inc.
TypeSubsidiary
IndustryMedical devices
FoundedDecember 1998 (1998-12)
FounderC. David Finch, Jr., MD and Jeffrey H. Burbank
Headquarters
Lawrence, Massachusetts
,
U.S.
ProductsSystem One
RevenueIncrease $393 million (2017)
Increase -$14 million (2017)
Total assetsIncrease $325 million (2017)
Total equityIncrease $213 million (2017)
Number of employees
3,800 (2017)
ParentFresenius Medical Care
Websitewww.nxstage.com
Footnotes / references
[1]

NxStage Medical, Inc. Is an American company that develops, manufactures, and markets systems for the treatment of chronic kidney disease, acute kidney injury, and hypervolemia. It is a subsidiary of Fresenius Medical Care. System One, a portable hemodialysis system, is the company's primary product.[1]

History

The company was founded by C. David Finch, Jr., MD[2] and Jeffrey H. Burbank in December 1998.[3]

In 2003, the company launched System One in the critical care market. It received Food and Drug Administration clearance for home hemodialysis in June 2005.[4]

In October 2005, the company became a public company via an initial public offering.[5]

On November 2, 2005, the company received the Nixon Peabody/Smith&Nephew Medical Device Innovation Award in the Start-Up category from the Massachusetts Medical Device Industry Council (MassMEDIC).[6]

In December 2014, the company received Food and Drug Administration clearance for System One to be used overnight while patients are sleeping.[7]

In August 2017, the company received Food and Drug Administration clearance for System One for solo home hemodialysis, without a care partner, during waking hours.[8]

In February 2019, the company was acquired by Fresenius Medical Care.[9][10]

References

  1. 1 2 "NxStage Medical, Inc. 2017 Form 10-K Annual Report". U.S. Securities and Exchange Commission.
  2. ↑ Who, Marquis Who's (2014-01-10). "C. David Finch Jr. MD". Elite American Physicians. Retrieved 2019-10-24.
  3. ↑ "Company Overview of NxStage Kidney Care, Inc". Bloomberg L.P. 15 July 2023.
  4. ↑ "NxStage Medical Receives FDA Clearance for Home Hemodialysis System" (Press release). Business Wire. June 29, 2005.
  5. ↑ "NxStage Medical rolls out lower-priced IPO". American City Business Journals. October 24, 2005.
  6. ↑ "MassMEDIC Honors NxStage Medical with Innovation Award for Portable Home Hemodialysis System" (Press release). Business Wire. November 2, 2005.
  7. ↑ Seiffert, Don (December 29, 2014). "NxStage nabs first-ever FDA approval for overnight home hemodialysis". American City Business Journals.
  8. ↑ "NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage® System One™" (Press release). PR Newswire. August 28, 2017.
  9. ↑ BANNOW, TARA (February 26, 2019). "Fresenius Medical Care closes $2 billion NxStage acquisition". Modern Healthcare.
  10. ↑ "Fresenius Medical Care completes acquisition of NxStage Medical" (Press release). PR Newswire. February 26, 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.